Literature DB >> 17203974

Identification of specific protein markers in microdissected hepatocellular carcinoma.

Christian Melle1, Günther Ernst, Olaf Scheibner, Roland Kaufmann, Bettina Schimmel, Annett Bleul, Utz Settmacher, Merten Hommann, Uwe Claussen, Ferdinand von Eggeling.   

Abstract

At present, the molecular mechanisms of hepatocellular carcinogenesis are not well-understood, and hepatocellular carcinoma (HCC) stays one of the most frequent and high-risk metastatic visceral neoplasms worldwide. For the identification of tumor-relevant proteins, we analyzed microdissected cells from nontumorous liver tissue (n = 28) and tissue derived from hepatic tumor center (n = 25), as well as tumor margin (n = 23). We unequivocally identified 53 proteins from hepatic tumor tissues by peptide fingerprint mapping and SELDI mass spectrometry that were separated using two-dimensional gel electrophoresis. Among a number of signals that were detected as significantly different in the protein profiling analysis, we identified for the first time ferritin light subunit (FLS) and adenylate kinase 3 alpha-like 1 (AK3), showing decreased expressions in hepatic tumor, as well as biliverdin reductase B (BVRB) that was upregulated in HCC. The use of ProteinChip technology in combination with tissue microdissection gives insight of the complex changes occurring at the protein level in hepatocellular cancer associated with tumor development and progression and resulted in three new potential diagnostically useful markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203974     DOI: 10.1021/pr060439b

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  20 in total

1.  Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

Authors:  Jintao Zhang; Kaijuan Wang; Jianzhong Zhang; Samuel S Liu; Liping Dai; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2011-05-03       Impact factor: 4.466

Review 2.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

3.  Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells.

Authors:  Raja Shekar Rachakatla; Sivasai Balivada; Gwi-Moon Seo; Carl B Myers; Hongwang Wang; Thilani N Samarakoon; Raj Dani; Marla Pyle; Franklin O Kroh; Brandon Walker; Xiaoxuan Leaym; Olga B Koper; Viktor Chikan; Stefan H Bossmann; Masaaki Tamura; Deryl L Troyer
Journal:  ACS Nano       Date:  2010-11-08       Impact factor: 15.881

4.  Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.

Authors:  Jian He; Zhao-Chong Zeng; Zuo-Lin Xiang; Ping Yang
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 5.  Emerging affinity-based techniques in proteomics.

Authors:  Shengnan Xie; Colby Moya; Betul Bilgin; Arul Jayaraman; S Patrick Walton
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

6.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

7.  KEGG spider: interpretation of genomics data in the context of the global gene metabolic network.

Authors:  Alexey V Antonov; Sabine Dietmann; Hans W Mewes
Journal:  Genome Biol       Date:  2008-12-18       Impact factor: 13.583

Review 8.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

9.  Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11.

Authors:  Christian Melle; Günther Ernst; Bettina Schimmel; Annett Bleul; Ferdinand von Eggeling
Journal:  PLoS One       Date:  2008-12-02       Impact factor: 3.240

10.  Differential tissue-specific protein markers of vaginal carcinoma.

Authors:  K Hellman; A A Alaiya; S Becker; M Lomnytska; K Schedvins; W Steinberg; A-C Hellström; S Andersson; U Hellman; G Auer
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.